Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis

Clinical trial NCT01872026 · COMPLETED

Trial details

NCT number: NCT01872026
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Patients on Stable Chronic Maintenance Dialysis Who Are Receiving Hemodialysis Therapy Pharmacodynamics of ASP7991 Pharmacokinetics of ASP7991

Start date: 2012-12-26
Primary completion: 2013-06-26
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.